NextPlay Technologies’ Longroot Selected by Ample Health to Lead Security Token Offering

NextPlay Technologies, Inc., a digital business ecosystem for digital advertisers, consumers, video gamers and travelers, reported that its licensed Longroot digital token offering platform will serve as the financial advisor and underwriter for Ample Health’s (‘Ample’) proposed security token offering (STO).

Marketing Technology News: MarTech Interview with Jeff Lortz, CEO at Creator by Zmags

Ample Health is an emerging cannabis company operating from seed to sale in Southeast Asia. The company is looking to use the proceeds from its STO to fund its development and global expansion.

Longroot will be responsible for structuring the offering and raising the initial capital to fund the STO. This will involve developing the registration statements for all relevant jurisdictions, including preliminary and final prospectuses. It intends to lead Ample through the entire regulatory approval process, and then assist in the pricing and launching the STO through the Longroot portal.

“This Ample Health STO represents a tremendous opportunity for us to represent a major client in the fast-growing global cannabis space,” commented Todd Bonner, director of Longroot (Thailand) Limited and chairman of NextPlay Technologies. “Once complete, we believe it will represent the first of many successful STOs for Longroot that we are currently advancing in our pipeline.”

Ample Health looks to take advantage of the global cannabis market which is projected to grow at a 32% compounded annual growth rate from $28.3 billion in 2021 to $197.74 billion by 2028, according to Fortune Business Insights.

Marketing Technology News: AiTrillion Recognized as a Momentum Leader in G2’s Winter 2022 Personalized Software Category

Akira Wongwan, CEO and co-founder of Ample Health, commented: “We selected Longroot to lead our STO due to its experienced management and well-established presence in the digital offering marketplace, as well as its Thai federal government licensing and oversight. Together, we believe this will ensure a highly-successful STO and the launch of our global cannabis platform.”

The proposed offering targets to raise between USD $100-250 million. Longroot will receive a management and placement fee on the proceeds raised due immediately upon closing of the offering, which is expected to occur by the summer of 2022. 


The information included in the press release is for informational purposes only. It is not intended to be, nor should it be construed as, an offer or solicitation for the purchase or sale of any financial instrument, security or digital currency, or as an official confirmation of any transaction. All market information, data and other information included herein are not guaranteed as to completeness or accuracy and are subject to change without notice.

This press release is not an offer of securities for sale in the United States. Securities may not be offered or sold in the United States absent registration or an exemption from registration. Any public offering of securities to be made in the United States will be made by means of a prospectus that may be obtained from Ample Health and will contain detailed information about the company and management, as well as financial statements.

Marketing Technology News: Metaverse Shopping Company, Valorabien, Launches Reg CF Funding Campaign on Wefunder

buy modafinil where to buy modafinil